Authors
Latest:
Adult Immunizations: Are Your Patients Up-to-Date?In the health-system setting, pharmacists must often prioritize their attention to treating the most acute medical condition a patient presents with; however, it is important to also consider opportunities to prevent disease.
Latest:
Community “Specialty†Pharmacy vs the CompetitionGiven the state of political affairs currently engulfing health care, our industry regularly gets vilified and is frequently a victim of misperception.
Latest:
Neostigmine Methylsulfate Injection (Bloxiverz)Bloxiverz, manufactured by Éclat Pharmaceuticals, is the first and only FDA-approved neostigmine methylsulfate injection.
Latest:
Implementation Strategy to Bring Medication Therapy Management Into High-ÂVolume Community PharmaciesThis study shows how medication therapy management can be integrated into challenging pharmacy work flow, and also assesses the resulting benefits, both clinical and financial.
Latest:
Direct and Indirect Cost Burden of Chronic Hepatitis CAn estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.
Latest:
Patient Adherence: Identifying Barriers and Defining SolutionsMajor patient and professional advocacy organizations discussed factors leading to patient nonadherence to prescription therapy and solutions for overcoming the major barriers.
Latest:
An Absence of Essential Skills in the Current Healthcare LandscapeWhether managing other healthcare workers or working on the frontline with patients every day, professionals can help foster a culture where learning soft skills is a priority.
Latest:
Why the Consumerization of Health Care Lies in Better CommunicationIt comes as no surprise that as health care organizations look for ways to improve outreach to their patients, they look first to HIPAA"compliant texting services.
Latest:
Are Pharmacy Schools Growing Too Fast?Pharmacy schools have been growing at an unprecedented rate, and if the trend continues as expected it could pose problems for the future success of the profession.
Latest:
Incentives for Filing a Product Through the 351(k) PathwaySteven Lucio of Novation discusses how Teva's Granix (tbo-filgrastim), which was filed through a 351(a) pathway, was approved for only 1 indication--and it was not the indication considered to be the "most definitive" for that particular product.
Latest:
Improve Pain Management With Precision PharmacotherapyLeveraging pharmacogenomic testing, simultaneous multidrug analysis can help prevent drug interactions affecting pain management.
Latest:
Adoption of a Uniform Standard for Pharmacy Technician Education: A Professionally Symbiotic or Heretical Concept?Significant changes in the delivery of health care services within the United States have given pharmacists and pharmacy technicians opportunities to advance in their roles and responsibilities.
Latest:
Second Look at Utilization of a Closed-System Transfer Device (PhaSeal)The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.
Latest:
Walgreens Severs Ties with ACOsIn a year marked by major changes for the company, Walgreens ends 2 of Its 3 ACO contracts.
Latest:
Outcomes-Based Contracts Can Shape the Future of Health CareOver the past decade, much of the health care economy has shifted from rewarding quantity (fee-for-service) to instead rewarding quality (outcome- and value-based payments).
Latest:
Help Prevent and Relieve Allergy SymptomsPharmacists can be essential resources for patients seeking advice on the selection and use of nonprescription medications.
Latest:
Benefits to Volunteering on Your Corporate Compliance TeamMany health care entities including hospitals, pharmaceutical manufactures, and retail have in place corporate compliance programs designed to identify fraud, waste, and abuse.
Latest:
Leadership as a New Practitioner: Finding Something Worth Fighting ForLeaders with a clear sense of what they are fighting for, and why, are better able to convey their vision to future followers and help others recognize the importance of their mission.
Latest:
Pharmacist Shares Screenshot of a Patient’s Prescription, Which Results in TerminationThe pharmacist shared the image with his spouse, who is also a pharmacist
Latest:
A Closer Look at New FDA Actions: Amgen's ProliaAmgen Inc's new monoclonal antibody Prolia (denosumab) is the first "biologic therapy" approved by the FDA for the treatment of osteoporosis in menopausal women.
